Neobio, Korea University sign MOU on development of new natural products

Published: 2008-08-29 06:21:00

Updated: 2008-08-29 06:21:00

Neobio, a leader in the field of cutting-edge biotechnology, said on August 25 that it signed a memorandum of understanding with the Korea University’s medical college to conduct joint research for the development of new natural drugs.

Under the agreement, the two sides will share information ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK